Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12738723rdf:typepubmed:Citationlld:pubmed
pubmed-article:12738723lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0332174lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0441771lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0205420lld:lifeskim
pubmed-article:12738723lifeskim:mentionsumls-concept:C0332283lld:lifeskim
pubmed-article:12738723pubmed:issue5lld:pubmed
pubmed-article:12738723pubmed:dateCreated2003-5-9lld:pubmed
pubmed-article:12738723pubmed:abstractTextTo determine the maximum-tolerated dose of docetaxel (DOC) in combination with carboplatin (CAR) and thoracic radiotherapy (RT), in the setting of trimodality treatment of patients with stage III non-small cell lung cancer (NSCLC).lld:pubmed
pubmed-article:12738723pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738723pubmed:languageenglld:pubmed
pubmed-article:12738723pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738723pubmed:citationSubsetIMlld:pubmed
pubmed-article:12738723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738723pubmed:statusMEDLINElld:pubmed
pubmed-article:12738723pubmed:monthMaylld:pubmed
pubmed-article:12738723pubmed:issn1078-0432lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:BermanStuart...lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:ChoiNoah CNClld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:MathisenDougl...lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:SugarbakerDav...lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:JohnsonBruce...lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:HerbstRoy SRSlld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:JännePasi APAlld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:SkarinArthur...lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:FidiasPanosPlld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:LuccaJoanJlld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:WirthLori JLJlld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:OstlerPatrici...lld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:LynchCathyClld:pubmed
pubmed-article:12738723pubmed:authorpubmed-author:LukanichJeann...lld:pubmed
pubmed-article:12738723pubmed:issnTypePrintlld:pubmed
pubmed-article:12738723pubmed:volume9lld:pubmed
pubmed-article:12738723pubmed:ownerNLMlld:pubmed
pubmed-article:12738723pubmed:authorsCompleteYlld:pubmed
pubmed-article:12738723pubmed:pagination1698-704lld:pubmed
pubmed-article:12738723pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:meshHeadingpubmed-meshheading:12738723...lld:pubmed
pubmed-article:12738723pubmed:year2003lld:pubmed
pubmed-article:12738723pubmed:articleTitleInduction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.lld:pubmed
pubmed-article:12738723pubmed:affiliationDepartment of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.lld:pubmed
pubmed-article:12738723pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12738723pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12738723pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12738723pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738723lld:pubmed